Back
Sarepta Therapeutics Stock Price Chart
Apple's Space Move Could Send This Pre-IPO Stock Soaring
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
41
SRPT
Sarepta Therapeutics
Last Price:
$105.29
Seasonality Move:
1.75%
7 Day Trial
ALL ACCESS PASS
$
7
Attention Investors: The 10 Best stocks for 2025 - yours FREE
Get Your Copy of "10 Best Stocks to Own in 2025" Here.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.
Sarepta Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 111.57 | Sell |
| 20-day SMA: | 114.25 | Sell |
| 50-day SMA: | 119.8 | Sell |
| 200-day SMA: | 128.55 | Sell |
| 8-day EMA: | 110.88 | Sell |
| 20-day EMA: | 113.91 | Sell |
| 50-day EMA: | 117.81 | Sell |
| 200-day EMA: | 123.39 | Sell |
Sarepta Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.94 | Sell |
| Relative Strength Index (14 RSI): | 33.84 | Sell |
| Chaikin Money Flow: | -502758 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (111.52 - 119.16) | Sell |
| Bollinger Bands (100): | (114.38 - 127.78) | Sell |
Sarepta Therapeutics Technical Analysis
| Feb 3 | Feb 4 | Feb 5 | Feb 6 | Feb 7 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb | ||||||||||
| 03 | 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Sarepta Therapeutics Stock
Is Sarepta Therapeutics Stock a Buy?
-
Sarepta Therapeutics share price is 107.95 while SRPT 8-day simple moving average is 111.57, which is a Sell signal.
-
The stock price of SRPT is 107.95 while Sarepta Therapeutics 20-day SMA is 114.25, which makes it a Sell.
-
Sarepta Therapeutics 50-day simple moving average is 119.80 while SRPT share price is 107.95, making it a Sell technically.
-
SRPT stock price is 107.95 and Sarepta Therapeutics 200-day simple moving average is 128.55, creating a Sell signal.
SRPT Technical Analysis vs Fundamental Analysis
Sell
41
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy or a Sell?
-
Sarepta Therapeutics stock is rated a SellThe current Sarepta Therapeutics [SRPT] share price is $107.95. The Score for SRPT is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
Sarepta Therapeutics Stock Info
Market Cap:
10.3B
Price in USD:
107.95
Share Volume:
620K
Sarepta Therapeutics 52-Week Range
52-Week High:
173.25
52-Week Low:
102.16
Sell
41
Sarepta Therapeutics (SRPT)
is a Sell
Sarepta Therapeutics Share Price Forecast
-
What is the Sarepta Therapeutics stock price today?The Sarepta Therapeutics stock price is 107.95 USD today.
-
Will SRPT stock go up or go down?Sarepta Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Sarepta Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Sarepta Therapeutics is overvalued.
Is Sarepta Therapeutics Stock a Buy?
-
Sarepta Therapeutics share price is 107.95 while SRPT 8-day exponential moving average is 110.88, which is a Sell signal.
-
The stock price of SRPT is 107.95 while Sarepta Therapeutics 20-day EMA is 113.91, which makes it a Sell.
-
Sarepta Therapeutics 50-day exponential moving average is 117.81 while SRPT share price is 107.95, making it a Sell technically.
-
SRPT stock price is 107.95 and Sarepta Therapeutics 200-day simple moving average is 123.39, creating a Sell signal.
Fundamental Analysis of Sarepta Therapeutics
Is Sarepta Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $2.70 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.63 per share, and an increase next year of $4.84 per share.
Technical Analysis of Sarepta Therapeutics
Should I short Sarepta Therapeutics stock?
-
SRPT Moving Average Covergence Divergence (MACD) indicator is -2.94, suggesting Sarepta Therapeutics is a Sell
-
Sarepta Therapeutics Relative Strength Index (RSI) is 33.84, which suggest Sarepta Therapeutics is oversold
-
The Bollinger Bands (25) for Sarepta Therapeutics is (111.52 - 119.16), which suggest Sarepta Therapeutics is a Sell
-
The Bollinger Bands (100) for Sarepta Therapeutics is (114.38 - 127.78), which suggest Sarepta Therapeutics is a Sell
* Sarepta Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.